SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: paul goldstein who wrote (523)9/19/1996 8:52:00 AM
From: Richard Mazzarella   of 4342
 
Paul, I agree that the price is low and everyone should have a "core" position. A "cured" patient announcement would explode this stock IMO. I have had some thoughts about PRLN just working to "bag" the "big ones" i.e. AIDS and cancer. I previously said that that's where the money is. That's true if you are there first with the product the market needs. However, you are up against the biggies like Merck etc.. Remember the technically superior computer Next going against IBM? EMIS had it's share price go up just for one minor drug (oral heparin). Maybe PRLN could be more successful (stock price wise) going for a "lesser goal"? The run at AIDS and cancer should be done just for humanity sake, but a less important success could do wonders for the stock, don't you think? Comments?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News